Keyword: counterfeit drugs

Plant Construction & Process Technology

Supply Chain Integrity and Patient Safety

27.09.2017 - Investigation into future trends in the medical and pharmaceutical sector shows that digitalization is changing supply chains in the healthcare industry. Such diverse issues like...

Plant Construction & Process Technology

Serialization in the Pharmaceutical Industry

19.10.2015 - Logistics heads and executives are asking themselves, “Do we need to approach serialization, or is it just a minor trend?” Is serialization pain or gain? Now is the time to act no...

Chemistry & Life Sciences

Buyer Beware, Patient Beware

02.07.2013 - On July 2, the Falsified Medicines Directive (FMD) went into full force: All APIs imported into the EU must be accompanied by written confirmations of quality by the regulatory...

News

U.S. Lawmakers Advance Bill on Prescription Drug Tracking

09.05.2013 - A U.S. House of Representatives panel advanced a bill on Wednesday on how the federal government should track prescription drugs as they move through the distribution chain, over...

News

U.S. FDA Cracks Down on Thousands of Websites for Selling Fake Drugs

04.10.2012 - The U.S. Food and Drug Administration on Thursday said it has cracked down on thousands of online pharmacies for selling potentially unsafe, unapproved or fake pharmaceuticals...

News

Toxic Capsules Help the Medicine Go down in China

18.06.2012 - Hou Zhihui breaks open a cold-medicine capsule, pours the powder on to a piece of steamed dough and folds it together. He passes the miniature bun to a colleague who pops it in her...

News

Fake Drugs Threaten Gains Made in War on Malaria

22.05.2012 - Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains made in the fight against the disease in the...

News

EU Plans to Block Fake Drugs Spark Industry Row

27.04.2012 - A European Union plan to tighten drug packaging rules in a bid to stamp out counterfeits has triggered a row between makers of big name medicines and those producing cheap generics...